BPI Sports A-HD, 28 Capsules

Anti-Aromatase Inhibitor & Testosterone Booster!

• (3s,4s)-4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[[3-methoxy-4-[(2s,3r,4s,5r,6r)-3, 4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-phenyl]methyl]oxolan-2-one: Research shows that this novel lignan-class compound has potent anti-estrogenic activity, with a potency factor comparable to the leading anti-aromatase prescription intervention. Arimedex HD is the first dietary supplement product to feature clinical dosed levels of this anti-estrogenic compound.
• 2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol: Research shows that this compound possesses powerful anti-estrogenic properties via multiple mechanisms. Specifically, this novel lignan-class compound has been shown to inhibit aromatase (it also shows synergistic/additive effect when taken in combination with the leading anti-aromatase prescription intervention), inhibit 3-hydroxysteroid dehydrogenase and 17-hydroxysteroid dehydrogenase, down-regulate 5 alpha-reductase, modulate tyrosine kinases as well as other protein kinases, and favorably modulate plasma free testosterone levels. Moreover, use of this compound prior to sustained physical exercise/exertion helps to reduce muscle damage via up-regulation of hepatic glutathione (GSH) levels and down-regulation of malondialdehyde (MDA) levels in skeletal muscle.
• 4-[(e)-2-(3,5-dimethoxyphenyl)ethenyl]phenol: Research shows this novel stilbenoid-class compound, which is methylated, is markedly more efficiently metabolized than non-methylated stilbenoid-class compounds for activation of the SIRT1 gene, up-regulation of plasma free testosterone production via selective estrogen receptor (ER) modulation, inhibition of aromatase, enhanced glucose metabolization, and improved insulin sensitivity. As a methylated stilbenoid-class compound, this compound is not sulfated by P450 enzymes, which translates into significantly greater bio-activity.
• s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone: Research shows that this phenolic-acid class compound exhibits bio-active androgenic activity via multiple pathways, such as marked down-regulation of malondialdehyde (MDA) levels, resulting in potent potential up-regulating effects on plasma free testosterone and luteinizing hormone. (NOTE: One published study showed an increase of up to 231.8% in plasma free testosterone (as compared to control), and an increase of up to 147.6% in luteinizing hormone (as compared to control).)
• phenethyl(e)-3-(3,4-dihydroxyphenyl)prop-2-enoate: Research shows that this remarkably active, potent and specific phenolic acid-class compound blocks inflammatory proteins, such as pro-inflammatory interleukin-1{beta}, and also inhibits prostaglandin synthesis in acute inflammation, and suppresses COX-II mRNA and protein. This compound is a specific inhibitor of 5 alpha-reductase (which down-regulates conversion to dihydrotestosterone) activity. Moreover, this compound acts as an estrogen receptor (ER) modulator.

Back to top